The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial
June 28, 2021
June 28, 2021
June 18, 2021
June 8, 2021
June 1, 2021
May 6, 2021
April 27, 2021
March 30, 2021
March 2, 2021
February 18, 2021
July 22, 2026
Milestone marks the transition of Low Dose IL-2 from clinical development to a scalable, regulatory-ready commercial manufacturing process Strategic s...
July 20, 2026
New registration expands access to minimally invasive skin microbiopsy for clinical, research, and wellness applications. Trajan today announced the H...
July 15, 2026
Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225